Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28…
New York City, Nov. 29, 2025 (GLOBE NEWSWIRE) -- November 28, 2025, CrazyBulk, a leading provider of Anabolic steroid alternatives,…
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST November 02, 2025 19:00 ET |…
August 20, 2025 09:48 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics,…
In competitive bodybuilding, muscular endurance can be the deciding factor between finishing strong or hitting an early wall. While strength…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…